162,163 Retatrutide (LY-3437943), a novel triple agonist developed by Eli Lilly that targets GLP-1R, GIPR and GCGR, has shown potential in preliminary clinical data for providing excellent blood sugar control and significant weight reduction
NCBI However, Wegovy and Ozempic are not approved for exactly the same conditions: Ozempic (semaglutide injection) is FDA-approved for adults with type 2 diabetes to: Improve blood sugar control, and Reduce the risk of major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes and established cardiovascular disease
Zepbound (tirzepatide) is a newer medication that acts as a dual agonist
Stephanie Ensley Person I have to do a three hour round trip drive to get to the nearest place where I can get this treatment so that I can stay healthy enough to have the vitality to go out and do what I can do for my community and serve
Sermorelin is GHRH(129)NH 2 : the first 29 residues of the 44-amino-acid human growth-hormone-releasing hormone, C-terminally amidated